Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Argentinian (MERVAL) Pharma Industry Analysis

UpdatedJun 30, 2026
DataAggregated Company Financials
Companies1
  • 7D-3.4%
  • 3M-5.4%
  • 1Y9.0%
  • YTD-21.3%

Over the last 7 days, the Pharma industry has dropped 4.0%, driven by pullbacks from every company within the industry. Over the past 12 months, the industry was up 14%.

Industry Valuation and Performance

Has the Argentinian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 30 Jun 2026AR$129.2bAR$119.6bAR$16.1b7.9x8x1.1x
Thu, 28 May 2026AR$131.2bAR$119.6bAR$16.1b8.2x8.2x1.1x
Sat, 25 Apr 2026AR$126.8bAR$126.7bAR$2.4b54.2x52.7x1x
Mon, 23 Mar 2026AR$140.7bAR$130.8b-AR$1,946,644,487.0055.8x-72.3x1.1x
Wed, 18 Feb 2026AR$165.4bAR$107.5b-AR$10,024,883,532.00n/a-16.5x1.5x
Fri, 16 Jan 2026AR$160.9bAR$108.5b-AR$8,970,776,885.00n/a-17.9x1.5x
Sun, 14 Dec 2025AR$182.3bAR$108.5b-AR$8,970,776,885.00n/a-20.3x1.7x
Tue, 11 Nov 2025AR$133.0bAR$108.5b-AR$8,970,776,885.00n/a-14.8x1.2x
Thu, 09 Oct 2025AR$95.3bAR$103.8bAR$8.1b7.8x11.8x0.9x
Sat, 06 Sep 2025AR$103.2bAR$104.5bAR$9.0b8x11.4x1x
Mon, 04 Aug 2025AR$130.6bAR$102.7bAR$16.3b6.4x8x1.3x
Wed, 02 Jul 2025AR$120.8bAR$104.7bAR$17.4b6.2x7x1.2x
Fri, 30 May 2025AR$125.2bAR$104.7bAR$17.4b6.3x7.2x1.2x
Sun, 27 Apr 2025AR$113.7bAR$100.1bAR$22.4b4.6x5.1x1.1x
Tue, 25 Mar 2025AR$139.4bAR$96.9bAR$24.8b4.9x5.6x1.4x
Thu, 20 Feb 2025AR$128.6bAR$42.6bAR$18.2b6.2x7.1x3x
Sat, 18 Jan 2025AR$141.9bAR$42.6bAR$18.2b6.3x7.8x3.3x
Mon, 16 Dec 2024AR$146.2bAR$42.6bAR$18.2b6.6x8x3.4x
Wed, 13 Nov 2024AR$157.2bAR$42.6bAR$18.2b6.4x8.7x3.7x
Fri, 11 Oct 2024AR$77.5bAR$40.7bAR$4.6b12.6x17x1.9x
Sun, 08 Sep 2024AR$77.7bAR$40.7bAR$4.6b12.5x17.1x1.9x
Tue, 06 Aug 2024AR$83.1bAR$41.1b-AR$3,264,658,797.003.9x-25.4x2x
Thu, 04 Jul 2024AR$84.4bAR$41.1b-AR$3,264,658,797.004.9x-25.8x2.1x
Sat, 01 Jun 2024AR$87.3bAR$41.1b-AR$3,264,658,797.005x-26.7x2.1x
Mon, 29 Apr 2024AR$74.9bAR$43.6b-AR$10,287,966,966.006.9x-7.3x1.7x
Wed, 27 Mar 2024AR$71.7bAR$9.6b-AR$4,702,241,388.0045.7x-15.3x7.4x
Fri, 23 Feb 2024AR$79.0bAR$9.6b-AR$4,702,241,388.0059x-16.8x8.2x
Sun, 21 Jan 2024AR$70.3bAR$10.3b-AR$4,704,193,685.0037.2x-15x6.8x
Tue, 19 Dec 2023AR$61.8bAR$10.3b-AR$4,704,193,685.0034.2x-13.1x6x
Thu, 16 Nov 2023AR$51.3bAR$13.0b-AR$2,496,856,221.00n/a-20.6x3.9x
Sat, 14 Oct 2023AR$51.1bAR$13.0b-AR$2,496,856,221.00n/a-20.5x3.9x
Mon, 11 Sep 2023AR$46.9bAR$18.8b-AR$150,001,147.0017.2x-312.6x2.5x
Wed, 09 Aug 2023AR$43.2bAR$18.8b-AR$150,001,147.0013x-288.1x2.3x
Fri, 07 Jul 2023AR$41.6bAR$18.8b-AR$150,001,147.0013.5x-277.6x2.2x
Price to Earnings Ratio

-277.6x


Total Market Cap: AR$41.6bTotal Earnings: -AR$150,001,147.00Total Revenue: AR$18.8bTotal Market Cap vs Earnings and Revenue0%0%0%
Argentinian Pharma Industry Price to Earnings3Y Average -24.2x202420252026
Current Industry PE
    There is only one company in the Argentinean Pharmaceuticals industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • Total earnings for the Pharmaceuticals industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 85% per year.
  • This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.

Industry Trends

Which industries have driven the changes within the Argentinian Healthcare industry?

AR Market-3.20%
Healthcare-3.38%
Pharma-3.38%
Pharma-3.38%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
No data available

Latest News

RICH
AR$1,570.00
Laboratorios RichmondC.I.F
7D
-3.4%
1Y
9.0%
ROSE
AR$164.00
Instituto Rosenbusch
7D
-3.0%
1Y
-7.3%